VITAS Hospice: Crisis Care for a Patient Playing Bingo

Whistleblower Justice Network

In the VITAS hospice lawsuit, Chemed and VITAS agreed to pay $75 million to resolve allegations that they billed Medicare for ineligible patients and for crisis care patients did not need or receive. The government alleged that admissions targets, bonuses and pressure on staff reached into the medical record. A nurse described instructions to record symptoms patients did not have and leave out improvement. For an insider, the case connects the business demands to what happened at the bedside and what Medicare was told.

The Department of Justice announced the settlement on October 30, 2017. At the time, the department called it the largest False Claims Act recovery from a hospice provider.

Chemed acquired VITAS in 2004. When the government announced its lawsuit in May 2013, VITAS operated in 18 states and the District of Columbia. This was a national hospice fraud case about both who entered the benefit and which level of care the company billed.

Admissions Targets and the Patient Record

The government alleged that VITAS admitted and retained patients who were not terminally ill while rewarding employees for bringing them in. Medicare hospice eligibility depends on a physician’s prognosis of six months or less if the illness runs its normal course. Continued eligibility depends on the patient’s condition at recertification. The alleged pressure reached the people supplying that clinical information.

According to the government’s first amended complaint, general managers who typically were not doctors or nurses evaluated and promoted staff according to admissions goals. The complaint alleged that those managers disregarded clinical objections and that VITAS paid nonclinical staff bonuses based on enrollment. DOJ’s original announcement also described incentives tied to longer stays.

The complaint alleged that one admissions nurse faced repeated pressure to reconsider an ineligibility decision until he agreed to admit the patient. A team doctor said a medical director overruled his refusal to certify patients, signing without justification. Another nurse described instructions to invent pallor and omit improvement from the chart. The alleged eligibility fraud reached from the chart to the doctor’s signature.

The government’s complaint also described discharge meetings where business managers discouraged removing patients even when they no longer qualified. Admissions, charting and discharge were parts of the same alleged practice: bring patients in, make the paperwork support their stay and keep billing.

The patient’s health care was at stake beyond the bill. Choosing hospice changes Medicare coverage for treatment of the terminal illness. An unsupported enrollment could put the hospice’s daily revenue ahead of the patient’s access to treatment outside hospice.

What Qualifies for Continuous Care in Hospice?

Continuous home care is for a brief crisis in which acute symptoms require skilled nursing to keep the patient at home. It requires at least eight hours of qualifying care in a day, predominantly nursing care, and payment depends on the hours supplied. The patient’s condition, the work performed and the time claimed have to tell the same story.

Medicare pays for four levels of hospice care. Routine home care pays for an enrolled day, whether or not a visit occurs that day. In its lawsuit announcement, DOJ described crisis care as the highest daily rate, paying hundreds of dollars more per patient than routine care. The February 2004 acquisition filing described VITAS’s profitability as largely dependent on managing the costs of care under daily payment. Staffing is both a clinical decision and a cost to the business.

A 2026 Kansas State University working paper, Quality, Reputation, and Reimbursement Design in the Hospice Industry, examined California hospice data and modeled quality using visits per patient-day. Its model found that paying partly by visit could maintain quality at lower Medicare spending. In the VITAS allegations, the sharper question was whether the higher payment corresponded to the nursing the patient needed and received.

The whistleblower’s first amended complaint described a scheduling practice built around the nursing requirement: a nurse on one long shift, an aide or homemaker on the other, with brief nurse visits added to the aide’s shift.

In other words, Vitas utilized this scheduling (in concert with short RN or LPN visits to a CNA or homemaker during their 12-hour shift) to ensure that slightly more than 50% of services were provided by an RN or LPN and therefore the entire 24-hour period could be billed under continuous home care, despite the fact that no such treatment was actually required or provided.

Whistleblower’s allegation, United States ex rel. Laura Spottiswood v. Chemed Corporation, et al., first amended complaint, paragraph 66(e)

The allegation puts the staffing roster beside the claim. It describes a schedule arranged to support the higher rate while the need for that care and its actual delivery were missing. That is the connection an employee handling schedules or hospice billing may recognize.

The government also alleged that VITAS marketed the service as intensive comfort care without explaining the acute-crisis requirement. The sales pitch and scheduling practice fit the government’s allegation of pressure to increase crisis-care billing.

When the Chart Contradicted the Crisis

The government’s complaint described patients billed at the crisis-care level whose own records showed ordinary activities or controlled symptoms. A nurse’s account made the mismatch plain:

One Vitas nurse stated that on more than one occasion, when Vitas sent her to the homes of patients whom she was told needed crisis care, she arrived only to find that the patients were at church, playing bingo, or having their hair done, and not in crisis.

Government’s allegation, United States v. Vitas Hospice Services, LLC, et al., first amended complaint, paragraph 64

In another example, the government alleged that VITAS continued billing crisis care for eleven days after its notes said a patient’s breathing symptoms were controlled, she was comfortable and she no longer had labored respirations. The chart recorded improvement. The billed level stayed higher.

The whistleblower’s complaint described a different discrepancy: a nurse’s sign-in sheet indicated she had left early, while progress notes appeared to record care at later times. Comparing a note with the staffing record could therefore reveal something that reading the note alone would miss.

Management’s concern with crisis-care margins also appeared in the government’s complaint. It quoted an internal message demanding an explanation for a decline:

Would you give me your thoughts on what caused this drop and what you will be doing to correct this in January? I will need this analysis by the end of the day today.

VITAS internal message quoted in the government’s United States v. Vitas Hospice Services, LLC, et al., first amended complaint, paragraph 60

The business wanted an answer about the margin that day. The patient records described a different question: why the company was billing for a crisis at all.

The Company’s Own Reviews Raised the Same Questions

The government alleged that VITAS had internal warnings about both crisis-care billing and hospice eligibility. Its complaint described a September 2010 review of the San Fernando, California program. Only 50% of the reviewed records were consistent with Medicare’s crisis-care criteria, and only 10% of the crisis-care claims matched the patients’ care plans, according to the complaint.

The review put a warning inside the business.

Separately, the government alleged that a limited internal eligibility review by medical directors led VITAS to discharge 75 to 80 patients it determined did not qualify. The complaint said VITAS did not repay Medicare for those patients and neither VITAS nor Chemed conducted a broader investigation.

The complaint also compared VITAS’s crisis-care use with the national average. For 2004 through 2011, it put VITAS’s share of service days at 4.42% to 5.25%, against a national range of 0.4% to 1.2%. The patient examples and internal reviews supplied the detail behind that comparison: what the charts said, what care was given and what the company had been told.

The same sequence appeared in Caris Healthcare’s 2018 settlement. Caris agreed to pay $8.5 million over allegations that included continuing to bill after internal audits, its chief medical officer and nurses raised eligibility concerns, while taking no meaningful action to identify earlier overpayments. In both cases, the warning and the response connected patient-level concerns to decisions higher in the company.

Three Whistleblower Cases and One National Resolution

Three whistleblowers brought separate qui tam cases. Those cases and the government’s own lawsuit came together in the national settlement in the Western District of Missouri. The Justice Department’s settlement announcement covered the national eligibility and continuous-care allegations for conduct during 2002 through 2013.

The different accounts matter to an insider. A nurse’s observations about visits and staffing and the government’s allegations about company targets describe different parts of the same billing operation. A person who sees one part can help explain what the claim alone leaves out.

The Five-Year Corporate Integrity Agreement

The resolution also brought a five-year corporate integrity agreement with the Department of Health and Human Services’ Office of Inspector General. Its requirements included independent review provisions, hospice-specific reviews, board resolutions and management certifications.

A Later Florida Audit Examined the Care Level

A separate inspector general audit issued in July 2022 examined VITAS Healthcare Corporation of Florida services from April 2017 through March 2019. Auditors found Medicare requirements unmet in 89 of 100 sampled claims. The problems included clinical records that did not support continuous home care or general inpatient care, and continuous-care services that were undocumented or unsupported.

This was a later payment audit, separate from the national settlement.

The audit returned to a familiar operational question: did the clinical record support the level of care Medicare paid for?

What Evidence Is Needed to Prove Fraud?

Our whistleblower experts connect the patient’s condition, the care billed and what management knew to build a case. The VITAS complaints show why those connections matter. A symptom entered on instruction, a nurse’s actual departure time or an internal review can explain a payment that looks ordinary on a billing screen.

Healthcare staff know what they observed and what they were asked to write. Scheduling and billing staff can connect visits and hours to the level submitted. Managers and compliance employees may know who received an audit, what the response was and whether the same billing continued. Our work with hospice whistleblowers brings those views together around the specific claims and decisions they explain. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Saw the Care Behind the Claim

If admissions targets or crisis-care demands changed the records you worked with, speak with our whistleblower experts about what happened. We use your knowledge of the patients and the business to build your strongest hospice whistleblower case. We bring in hospice fraud whistleblower lawyers who understand eligibility and nursing-hour disputes, and stay beside you through the case.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365